Erythropoietin use in patients on chronic hepatitis C treatment: Incidence of thromboembolic events and hepatocellular carcinoma

被引：0
|
作者：
Werner, Kristina T.
Rosati, Marianne J.
Vargas, Hugo E.
Byrne, Thomas
Rakela, Jorge L.
机构：
来源：
GASTROENTEROLOGY | 2008年 / 134卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A843 / A843
页数：1
相关论文
共 50 条
  • [1] Incidence of hepatocellular carcinoma reduced by phlebotomy treatment in patients with chronic hepatitis C
    Sasaki, Shoichi
    Nirei, Kazushige
    Matsuoka, Shuniti
    Nakamura, Hitomi
    Moriyama, Mitsuhiko
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 383 - 384
  • [2] Incidence of Hepatocellular Carcinoma Reduced by Phlebotomy Treatment in Patients with Chronic Hepatitis C
    Nirei, Kazushige
    Matsuoka, Shuniti
    Nakamura, Hitomi
    Matsumura, Hiroshi
    Moriyama, Mitsuhiko
    INTERNAL MEDICINE, 2015, 54 (02) : 107 - 117
  • [3] The incidence of hepatocellular carcinoma in patients with chronic hepatitis C after interferon treatment
    Miyajima, I
    Sata, M
    Kumashiro, R
    Uchimura, Y
    Ide, T
    Suzuki, H
    Tanikawa, K
    ONCOLOGY REPORTS, 1998, 5 (01) : 201 - 204
  • [4] Erythropoietin does not increase the frequency of thromboembolic events or hepatocellular carcinoma in hepatitis C patients treated with combination antiviral therapy
    Gallegos-Orozco, Juan F.
    Werner, Kristina T.
    Rosati, Marianne
    Byrne, Thomas J.
    Balan, Vijayan
    Vargas, Hugo E.
    Rakela, Jorge
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (08): : 2161 - 2162
  • [5] HEPATOCELLULAR CARCINOMA INCIDENCE IN CHRONIC HEPATITIS C PATIENTS ACCORDING TO ANTIVIRAL TREATMENT STATUS
    Purevsambuu, T.
    Bota, S.
    Hucke, F.
    Hofer, H.
    Ferenci, P.
    Sieghart, W.
    Peck-Radosavljevic, M.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S446 - S447
  • [6] Interferon for decreasing the incidence of hepatocellular carcinoma in patients with chronic hepatitis C
    Hayashi, N
    Kasahara, A
    ONCOLOGY, 2002, 62 : 87 - 93
  • [7] Effect of interferon on incidence of hepatocellular carcinoma in patients with chronic hepatitis C
    Soga, K
    Shibasaki, K
    Aoyagi, Y
    HEPATO-GASTROENTEROLOGY, 2005, 52 (64) : 1154 - 1158
  • [8] Liver stiffness and the incidence of hepatocellular carcinoma in patients with chronic hepatitis C
    Nakayama, Yuji
    Takeda, Tadashi
    Yasuda, Takahiro
    Nakaya, Mika
    Nakahara, Kenishi
    Fujii, Hideki
    Kobayashi, Sawako
    Iwai, Shuuji
    Enomoto, Masaru
    Tamori, Akihiro
    Sakaguchi, Hiroki
    Habu, Daiki
    Seki, Shuichi
    Kawada, Nonfumi
    GASTROENTEROLOGY, 2007, 132 (04) : A780 - A780
  • [9] The Incidence of Hepatocellular Carcinoma from Chronic Hepatitis C Patients Aft er Interferon Treatment
    Kikuchi, Kaoru
    Yamaguchi, Yutaka
    Yosida, Yukio
    Chinen, Kenji
    Kubota, Tomiaki
    Arashiro, Masayuki
    Shimabukuro, Yoshiki
    Keida, Yoshihide
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S135 - S135
  • [10] Incidence of hepatocellular carcinoma after interferon therapy in patients with chronic hepatitis C
    Onodera, H
    Ukai, K
    Suzuki, M
    Minami, Y
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 181 (02): : 275 - 283
12345